Introduction {#S1}
============

Persistent organohalogen compounds are widespread industrial chemicals that disturb normal functioning of numerous hormonal and homeostatic processes in humans ([@R12]). Due to their ecological and biological persistence, as well as their relative toxicity to humans, environmental exposure to chemicals such as polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs), and certain long-chained poly- and perfluoroalkyl substances (PFASs) have been largely phased-out or banned in the United States. Despite decreased production, these legacy chemicals are still widely detected in the U.S. population ([@R45]; [@R21]), including pregnant women ([@R56]; [@R32]). Pregnancy is a critical window for exposure to organohalogen chemicals. PBDEs, PCBs, and PFASs can cross the placental barrier to a developing fetus ([@R32]) and have been detected in various biological media, including cord blood, amniotic fluid, and breast milk ([@R2]). Furthermore, prenatal exposure has been associated with a range of adverse health effects to both women and children, including pregnancy complications and neurodevelopmental harm in childhood ([@R51]).

In the U.S., almost all pregnant women have detectable concentrations of one or more PBDE, PCB and PFAS chemicals in their serum ([@R56]); although, more recent biomonitoring data suggest maternal concentrations of certain organohalogen classes are declining ([@R52]; Hurley et al. 2016; [@R37]). Not all population groups in the U.S. may be uniformly experiencing exposure declines since sources of exposure can vary by sociodemographic, geographic, occupational and lifestyle factors. Nationally, serum organohalogen concentrations have differed by race/ethnicity and poverty status in U.S. women of childbearing age ([@R48]). Biomonitoring studies of organohalogens during pregnancy have also shown economically-disadvantaged, minority, and urban communities have higher overall concentrations ([@R22]; [@R4]; [@R55]; [@R50]). In addition to chemical stressors, these communities are also disproportionately burdened by non-chemical stressors ([@R34]; [@R43]; [@R13]).

Prior research has primarily focused on evaluating sociodemographic determinants of individual organohalogen concentrations in pregnant populations; however, multiple chemical classes have been measured simultaneously in pregnant women ([@R56]; [@R5]), raising the need to better characterize cumulative exposures. Few studies have attempted to characterize profiles of environmental mixtures during pregnancy ([@R39]; [@R28]). Only one recent U.S. study we are aware of has examined determinants of chemical mixtures during pregnancy ([@R25]).

This study aims to examine variability in concentrations of 52 persistent organohalogen chemicals from four chemical classes (PBDEs, hydroxylated PBDE metabolites (OH-PBDEs), PCBs, PFASs) and combined mixtures of these individual chemicals in a unique population of racially/ethnically diverse, low-income, overweight, pregnant women from Northern California.

Methods {#S2}
=======

Study population and exclusion criteria {#S3}
---------------------------------------

The Maternal Adiposity, Metabolism, and Stress (MAMAS) study was an eight-week intervention designed to determine whether certain stress-reduction techniques could decrease maternal stress and increase healthy weight gain during pregnancy ( on [www.clinicaltrials.gov](http://www.clinicaltrials.gov/)) and has been described in detail elsewhere ([@R7]; [@R49]).

Women were eligible for the study if they were 8--23 weeks pregnant, 18--45 years old, English-speaking, annual household income of up to 500% of the federal poverty level, and a self-reported pre-pregnancy body mass index (BMI) between 25--40 kg/m^2^. Subsequent medical record confirmation of pre-pregnancy BMI revealed seven participants with a pre-pregnancy BMI between 23.0 and 25.0 kg/m^2^, and three participants with a pre-pregnancy BMI between 40.0 and 42.1 kg/m^2^; however, all participants were retained in the intervention arm. Participants were recruited in the San Francisco Bay area at locations that provided prenatal care and/or social services. Women were excluded if they had polycystic ovarian syndrome and were treated with Metformin, active substance abuse, recent weight loss, chronic corticosteroid use, pre-existing diabetes, an eating disorder, a positive early pregnancy diabetes screening test, multiple gestation, or a history of gastric bypass surgery. The 215 participants were assigned to either a control group or a mindfulness-based stress reduction and healthy eating behavioral intervention. Enrolled women completed questionnaires at baseline (10 to 24 weeks gestation) from 2011--2013 and were followed until 6--9 months postpartum. The MAMAS study was approved by the University of California, San Francisco (UCSF) Committee on Human Research and the California Pacific Medical Center, University of California, Berkeley and Contra Costa Regional Medical Center and Health Centers Institutional Review Boards. All participants provided informed consent.

Only the women in the intervention arm provided biological samples and are therefore the focus of the present analysis. There were 105 participants who met study inclusion criteria, but seven participants lacked baseline biological samples or data on multiple maternal characteristics, leaving 98 women for analysis.

Maternal organohalogen measurements {#S4}
-----------------------------------

A 10 mL fasting maternal blood sample was collected at the baseline visit (between 10--24 weeks of gestation) in an additive-free red top tube (BD Vacutainer) by trained UCSF staff. Blood was allowed to clot for 1h, then placed on ice for a subsequent 1h. Samples were centrifuged at 1300g for 10 min at 4°C and 1 mL serum was aliquoted into five vials. Samples were stored in an −80°C freezer for up to three months. Serum was analyzed for individual PBDEs, OH-PBDEs, PCBs, and PFASs at the Environmental Chemistry Laboratory of the Department of Toxic Substances Control (Berkeley, CA, USA).

Detailed analytical laboratory methods, including sample extraction, instrumentation and procedures, validation, and quality control have been described on this study population in detail elsewhere ([@R63]). Briefly, serum sample extraction and analytical methods were performed for 19 PBDEs, 8 OH-PBDEs, 15 PCBs, and 11 PFASs based on commonly used techniques ([@R61]; [@R37]). We present on aggregated linear and branched isomers of both PFOS and PFOA. PBDE congener, OH-PBDE metabolite, and PCB congener concentrations were measured using gas chromatography/ high-resolution mass spectrometry. An online solid phase extraction liquid chromatography tandem mass spectrometry method was employed to determine concentrations of PFAS analytes in maternal serum ([@R52]). Serum lipid analysis was conducted at Boston Children's Hospital. A common method ([@R38]) was used to calculate total serum lipids based on measured total cholesterol, triglycerides, and phospholipids. Each analyte's method detection limit (MDL) was defined as three times the standard deviation of the concentrations of blank analytes; further information on sample MDLs are published elsewhere ([@R63]).

A multiple imputation method was employed for values below the MDL using a log-normal probability distribution with parameters calculated using maximum likelihood estimation ([@R17]; [@R1]; [@R61]). Lipid-soluble chemical concentrations (PBDEs and PCBs) were normalized using total serum lipids (ng/g lipid), whereas hydroxylated PBDE and PFAS analytes were reported as wet-weight concentrations (ng/mL).

Participant characteristics {#S5}
---------------------------

Participant sociodemographic and behavioral information was collected through a questionnaire administered at baseline, which has been described in detail elsewhere ([@R49]). Gestational age at enrollment, pre-pregnancy BMI, and parity were initially self-reported, then confirmed via medical records for all women. Gestational age at enrollment and expected delivery date were self-reported and later confirmed via medical records. For most participants, expected delivery date was calculated based on last menstrual period and ultrasound measurements in early pregnancy. A 24-hour dietary recall was administered by trained interviewers at baseline.

A number of potential participant characteristics were considered for statistical analysis based on a review of the literature. Sociodemographic characteristics include race/ethnicity (White or Other, African American, Latina), poverty status (annual household income \>100%, ≤ 100% of the 2011 federal poverty level), highest educational attainment (≤ high school graduate, \> high school graduate), and marital status (single/separated/divorced, married/in a relationship/engaged). Dietary measures include food insecurity and the Alternative Healthy Eating Index modified for Pregnancy (AHEI-P) scale assessed at baseline. Food insecurity was determined by the ten-point U.S. Household Food Security Survey Module (US Department of Agriculture 2012) and then dichotomized into marginal-to-high food security (i.e., food secure households) and low-to-very low food security (i.e., food insecure households). The Alternative Healthy Eating Index modified for Pregnancy (AHEI-P) is a 90-point, multicomponent scale based on the 2010 AHEI (US Department of Agriculture 2010), which categorizes the quality intake of fruits, vegetables, meat, and nutrients, but excludes AHEI components that are generally avoided during pregnancy (e.g., alcohol consumption). We also considered the following behavioral and biological characteristics for our statistical models: gestational age (weeks at enrollment), pre-pregnancy BMI (kg/m^2^), BMI at baseline (kg/m^2^), parity (continuous), smoking status (current/former smoker versus never smoked), and lipid concentrations (g/mL).

Maternal adiposity was considered in our analysis because lipophilic organohalogens bioaccumulate and are retained in fat tissue. We chose pre-pregnancy BMI over baseline BMI in models because it temporally precedes natural gestational weight gain and, therefore, more likely reflects long-term chemical exposures of lipophilic organohalogens. Additionally, baseline visits for participants varied across a 14-week window when greater weight gain may occur. BMI at baseline visit was highly correlated with pre-pregnancy BMI (Spearman r=0.89; p\<0.001).

Statistical analysis {#S6}
--------------------

Descriptive statistics, including geometric means (GM) and geometric standard errors (GSE), were calculated for individual and total sum chemical concentrations. Of the 52 organohalogen chemicals available, individual chemicals were further examined for the subset of chemicals that were detected in at least half of the participants (i.e., detection frequency \[DF\] ≥50%), which includes four PBDE congeners (BDE-47, −99, −100, −153), two OH-PBDE metabolites (5-OHBDE-47, 6-OHBDE-47), three PCB congeners (PCB-138, −153, −180), and five PFAS analytes (perfluorohexane sulfonate \[PFHxS\], perfluorooctane sulfonate \[PFOS\], perfluorooctanoic acid \[PFOA\], perfluorononanoic acid \[PFNA\], and perfluorodecanoic acid \[PFDeA\]). We also calculated summary exposure metrics. For chemicals with a ≥50% DF, we summed congener or analyte concentrations for ΣPBDEs, ΣOH-PBDEs, ΣPCBs, and ΣPFASs. Prior to our statistical analysis, we natural log-transformed serum concentrations given the distributions were skewed and non-normal.

Relationship between maternal characteristics and chemical concentrations were initially examined using bivariate linear regression models, and associations with a p-value \<0.20 in any models were chosen for further "exploratory" analysis ([Supplementary Tables 1](#SD1){ref-type="supplementary-material"} and [2](#SD1){ref-type="supplementary-material"}). Subsequently, retained variables were fitted into a model and backwards elimination was employed, with a significance level of *p*\<0.05. Final multivariable linear regression models were used to evaluate chemical class-specific participant characteristics identified by backward elimination and individual maternal serum organohalogen concentrations. Regression coefficients and 95% confidence intervals (CIs) are provided, as well as an adjusted R-squared to measure the proportion of variation explained by included variables. Both descriptive statistics and multivariable linear regression models for ΣPBDEs, ΣOH-PBDEs, ΣPCBs, and ΣPFASs were also examined. To examine the effect of lipid normalization on our results, we ran additional sensitivity analyses using wet-weight concentrations of PBDEs and PCBs and adding log-adjusted total serum lipids as an independent covariate in our final models. Test for effect modification by income or race/ethnicity on chemical concentrations was determined by adding cross product terms into final models. To further explore the role of poverty status on the relationship between potential participant characteristics and chemical exposures, we also examined the association of race/ethnicity and chemical concentrations after stratifying by poverty status and while controlling for maternal age, pre-pregnancy BMI, and parity (not shown).

We used three methods of grouping chemicals: hierarchical clustering, a "chemical burden" sum score approach, and principal components analysis (PCA). We chose these unsupervised approaches (i.e., not informed by an outcome) for their variable reduction strategies which account for multicollinearity, and to identify exposure groups based on co-occurrence. We examined Spearman correlations between all individual chemicals and their chemical classes, and classified these correlations as high \[(+/−) 0.60 to 1.00\], moderate \[(+/−) 0.40 to 0.59\], or weak \[0.00 to (+/−) 0.39\]. An agglomerative hierarchical clustering approach was performed using the value of "1 minus the correlation coefficient (*r*)" to calculate the dissimilarity index, which ultimately allows for grouping of the most correlated terms to determine profiles of chemical exposures in the cohort. A heat map was produced to visualize groupings. To examine the "chemical burden" to each study participant, a sum count score was calculated for each participant by adding the number of highly detected chemicals that had concentrations in the top 25^th^ percentile of each chemical's distribution (potential range in each participant: 0--14). For example, an individual identified with the top 25^th^ percentile serum concentrations of two PFAS, two PBDEs, one OH-PBDE, and two PCB analytes would be assigned a "chemical burden" sum count score of seven. A cumulative frequency plot of the sum score by all participants was produced to visually examine if certain participants had high exposures to multiple chemicals within and across chemical classes. To account for the large number of correlated exposure terms and further understand the correlation structure of our data, we employed PCA, which categorizes correlated variables into artificial factors while maximizing the amount of variance in the dataset. We used log-transformed values for each individual chemical with a ≥50% DF. Principal components (PCs) were chosen based on eigenvalues \> 1.0 and visual analysis of a scree plot. Varimax rotation was employed to produce optimal components. An individual chemical with a factor loading \>0.50 was considered to be a critical chemical of a component. Using backward selection, linear regression analysis was used to determine if any participant characteristics were associated with each principal component. All significant variables were fitted in final multivariable linear regression models.

All statistical analyses were conducted in SAS version 9.3 (SAS Institute, Cary, NC) or in R software version 3.3 (<https://cran.r-project.org/>).

Results {#S7}
=======

The study sample had substantial racial and ethnic heterogeneity, with an equal distribution of Latina women (33.7%), non-Hispanic African American women (32.7%), and non-Hispanic White women or women from other races/ethnicities (33.7%) ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Almost half of the women (47.8%) were living at or below the 2011 federal poverty level. Participants were more likely to have at least a high school education (65.3%) and to be in a relationship, engaged or married (66.3%). By design, all of the participants were overweight and 44.9% had an obese pre-pregnancy BMI (≥30 kg/m^2^). Almost 40% of participants were categorized as having low or very low food security (i.e., food insecure), and half scored below the 50^th^ percentile for the AHEI-P, indicating a poor quality diet.

Fourteen of the 52 chemicals were detected in ≥50% of the population with BDE-47, −99, −153, PCB-153, PFNA, PFOS, PFOA, and PFHxS detected in \>85% of participants. Hierarchical clustering of all chemicals within and across chemical classes revealed high within-chemical class and low across-chemical class correlation ([Figure 1](#F1){ref-type="fig"}). BDE-47, −99, and −100 were highly correlated with each other, and were weakly-to-moderately correlated with BDE-153. OH-PBDEs were highly correlated with each other, and strongly-to-moderately correlated with parent PBDE congeners. PCB-153 and PCB-180 were highly correlated with each other, and moderately correlated with PCB-138. Moderate to strong positive correlations were seen among some PFAS analytes, with two clustered groupings of (a) PFHxS and PFOS, and (b) PFDeA, PFNA and PFOA.

In multivariable analysis, African American women had higher GM concentrations of BDE-100 and −153, whereas Latina women had lower GM concentrations of 6-OHBDE-47 and ΣOH-PBDEs, compared to women who were White or of other races/ethnicities ([Table 3](#T3){ref-type="table"}). A higher pre-pregnancy BMI was positively associated with higher PBDE and OH-PBDE concentrations in unadjusted models; however, after adjusting for race/ethnicity, education, and parity, the association only remained significant for BDE-100. Higher educational attainment was positively associated with higher exposure to PBDEs and OH-PBDEs in unadjusted models, and this association remained significant for BDE-99 in adjusted models. After adjustment, parity was inversely associated with BDE-100, 5-OHBDE-47, and ΣOH-PBDEs exposures. Results were similar in exploratory models ([Supplemental Table 1](#SD1){ref-type="supplementary-material"}).

Maternal age and/or poverty status were significantly associated with individual and aggregate PCB concentrations, accounting for 31 to 47% of the variance in multivariable linear regression models ([Table 4](#T4){ref-type="table"}). For final adjusted models of PCBs, an increase in maternal age was associated with a significant increase in log maternal serum concentrations of PCB-138, −153, −180, and ΣPCBs. After controlling for maternal age, women living at or below the poverty level had significantly lower GM concentrations of PCB-138 and ΣPCBs, compared to women living above the poverty level. There was little change in results when we expanded our final models to include additional participant characteristics such as race/ethnicity, education, pre-pregnancy BMI, gestational age, marital status, and/or AHEI-P score ([Supplemental Table 2](#SD1){ref-type="supplementary-material"}), with the exception of PCB-180 becoming significantly associated with poverty status. Log serum PFOS concentrations were significantly higher in women living in food insecure households, compared to women who had marginal to high food security ([Table 4](#T4){ref-type="table"} and [Supplemental Table 2](#SD1){ref-type="supplementary-material"}). No additional participant characteristics were associated with any PFAS analytes in final and exploratory models. When total serum lipids were adjusted for in finals models for wet weight concentrations of PBDEs and PCBs, the magnitude and direction of results were similar ([Supplemental Tables 3](#SD1){ref-type="supplementary-material"} and [4](#SD1){ref-type="supplementary-material"}). We did not observe evidence of effect modification of poverty status for associations between race/ethnicity and environmental exposures (data not shown).

[Figure 2](#F2){ref-type="fig"} shows each participant's "chemical burden" sum score, by chemical class, for chemicals with a concentration greater than the 75^th^ percentile concentration of the distribution. A median of 5 chemicals (range: 3--10 chemicals) were present; at least three of the four chemical classes examined were present in each participant's serum at concentrations in the top 25^th^ percentile relative to the study population. No association was observed between the "chemical burden" sum score and participant characteristics (not shown). When PCA was conducted, four PC groupings were determined: (PC1) PBDEs and OH-PBDEs, (PC2) PCBs, (PC3) PFNA, PFOA, and PFDeA, and (PC4) PFHxS and PFOS; these four PCs explained 70% of the variance ([Table 5](#T5){ref-type="table"}). In multivariable analyses ([Table 6](#T6){ref-type="table"}), race/ethnicity and pre-pregnancy BMI were significantly positively associated with PC1 loadings (PBDEs and OH-PBDEs). Maternal age was positively associated with PC2 (PCBs), and parity was inversely associated with PC2. There were no significant participant factors of either PC3 (PFNA, PFOA, PFDeA) or PC4 (PFHxS and PFOS) loadings.

Discussion {#S8}
==========

In our analysis of a unique pregnancy cohort of overweight, lower-income women from California, we found a variation in sociodemographic characteristics associated with individual organohalogen chemicals and their chemical classes. We explored associations between select maternal characteristics and both individual chemicals and aggregate groupings. In individual, total sum and aggregate analyses, African American women had increased maternal serum PBDE and OH-PBDE concentrations, and Latina women had lower PBDE/OH-PBDE concentrations. Other significant factors of PBDE/OH-PBDE included higher pre-pregnancy BMI and higher educational attainment, while parity was associated with lower levels. PCB concentrations were positively associated with maternal age, similar to other pregnancy cohorts ([@R55]; [@R20]). In this lower income cohort, those living at or below the poverty level had significantly lower PCB concentrations, supporting results from national estimates ([@R48]).

Five PFAS analytes were highly detected in the population, with PFNA, PFOS, PFHxS, and PFOA at ≥98% DF. PFAS GM concentrations were similar to, or lower than, other North American pregnancy or population-based cohorts ([@R30]; [@R33]; [@R29]; [@R46]; [@R48]). Interestingly, we found that participants from households that were food insecure had significantly higher maternal serum PFOS concentrations than those who were food secure. In general, diet is an important contributor to PFAS concentrations in pregnant women ([@R15]; [@R41]; [@R31]). Poorer dietary quality and food availability, as measured by food insecurity, may be indicators for higher consumption of PFAS-contaminated foods. PFAS compounds have been detected in food packaging materials ([@R59]; [@R42]), can migrate into food items ([@R47]), and have been associated with fast food consumption ([@R16]) and takeaway containers (Bonorow et al. 2019). Given the variability in concentrations across food sources, future consideration should be given to account for dietary quality. Exposure to PFASs through a variety of sources, including diet, consumer products, and drinking water, further complicate the ability to identify patterns using biomonitoring data alone. Based on both hierarchical clustering and PCA, two groupings emerged: (1) sulfonic (PFHxS and PFOS) and carboxylic acids (PFDeA, PFNA, and PFOA). PFHxS and PFOS are long-chained perfluoroalkyl sulfonate analogues with the longest half-lives in human serum ([@R36]), which may increase the likelihood of bioaccumulation. PFOS and PFHxS have been associated with certain exposure sources including aqueous film forming foams, microwaveable food, and waterproof clothing ([@R40]; [@R57]; Sienbenaler et al. 2017). Sources of exposure to carboxylic acids are diverse, though indirect sources include oil- and water-repellant applications of fluorotelomer alcohols and polyfluoroalkyl phosphate esters ([@R10]). Certain long-chain PFAS chemicals have been linked to adverse childhood neurodevelopment ([@R6]; [@R53]), decreased fetal growth ([@R26]), immune suppression ([@R35]), metabolic ([@R46]; Liu et al. 2018) and carcinogenic ([@R3]) effects. Within our study population, maternal PFASs, including PFOS, PFOA, and ΣPFASs, were associated with biomarkers of inflammation ([@R63]). Given the ubiquity of PFAS exposure sources and continued detection of both long-chained and newer shorter-chained PFASs in the environment and biomonitoring studies, further characterization of PFAS exposures and their sources is warranted.

*In utero* PBDE exposure continues to be a concern for numerous adverse health outcomes, including sufficient evidence of a causal effect on childhood neurodevelopmental outcomes ([@R27]). In our study, we found four PBDE congeners at detectable concentrations in \>75% of the study population, with BDE-47 detected in all participants. Two lower brominated hydroxy-BDEs metabolites were also found in at least half of the study population, albeit at lower concentrations. It is possible our high detection rate of the lower brominated PBDE congeners was a result of their longer half-life in the body and higher absorption rate compared to the higher brominated PBDE congeners ([@R8]). Median PBDE concentrations in this cohort were either higher ([@R33]) or similar ([@R37]) to other Northern California cohorts, and higher than the general US population ([@R48]). As a result of California 2006 ban and EPA's 2014 phase out of PBDEs, concentrations of PBDEs in California pregnant women have been declining (Zota et al. 2016; [@R37]). While exposure is decreasing overall, our results showing African American women with elevated PBDE levels suggest persistence of racial/ethnic disparities in exposures. Similarly elevated maternal PBDE/OH-PBDE concentrations were seen among African American women when compared to Latina women in three separate pregnancy cohorts ([@R18]; Cowell et al. 2017; [@R37]). As noted previously ([@R60]; [@R23]), racial disparities may be related to differences in exposure to PBDE-contaminated dust released from treated furniture and poorer housing quality, as seen in a study of dust levels in California homes ([@R54]). An alternative explanation for the observed differences in body burdens by race/ethnicity may be due to differences in PBDE metabolism by race/ethnicity.

In our cohort restricted to overweight and obese pregnant women, we still found pre-pregnancy BMI was significantly associated with increased maternal PBDE concentrations after lipid adjustment. Adiposity is linked to higher PBDE concentrations, as PBDEs are lipophilic and stored in adipose tissue. Growing evidence also suggest these chemicals have an obesogenic effect, and may play a causal role in adipogenesis ([@R24]). In our same study population, [@R63] found obesity modified the association between certain persistent organohalogens and biomarkers of inflammation during pregnancy. Given the proportion of women entering pregnancy as overweight or obese has been increasing in the U.S. ([@R11]), additional research is needed to examine the interplay of obesity and chemical concentrations during pregnancy, and their impact on health.

We detected the three most common non-dioxin-like PCB congeners (PCB-138, −153, −180) in more than half of the population, with PCB-153 measured in most serum samples. PCB-153 and PCB-180 were highly correlated with each other, and moderately correlated with congener 138. It is not surprising that age was positively associated with higher PCB concentrations in our population, reflecting the bioaccumulative nature of these highly lipophilic compounds. Younger women are less likely to have been exposed to PCB-containing consumer products as production and use have been phased out since 1979. Our study also indicates that women living at or below poverty had lower PCB levels, similar to other studies examining socioeconomic status and PCB concentrations ([@R4]; [@R50]). Underlying justification of socioeconomic differences in PCB concentrations have been poorly explained. One explanation is socioeconomic differences in fish consumption, which is a strong predictor of PCB concentrations ([@R58]). Further exploration into this potential disparity is warranted.

We used three unsupervised approaches to group chemicals into mixtures, all with differing purposes to characterize multiple chemical exposures in our population. Our use of a maternal "chemical burden" sum score revealed all participants had all four chemical classes present at concentrations in the top 25^th^ percentile relative to the study population in their blood during pregnancy. Our use of this metric which characterized across-class chemical profiles during pregnancy is supported by conclusions of concomitant multi-chemical exposures from other pregnancy cohorts ([@R56]; [@R39]; [@R14]; [@R25]). Hierarchical clustering and PCA had similar results for grouping chemical exposures. Although the "chemical burden" sum score identified women who had relatively high concentrations of multiple chemicals in their serum, the apparent lack of cross-chemical-class groupings suggest that exposure sources and metabolic pathways vary across chemical classes. These unsupervised methods to aggregate chemical exposures rely on statistical associations such as Euclidian distance or correlations to determine groupings. A recent study, which used unsupervised methods to examine predictors of chemical mixtures during pregnancy, found that determinants of chemical mixtures were similar to the determinants of individual chemicals. They also found evidence of racial/ethnic differences among certain chemical groupings ([@R25]). To better understand the association between chemical mixtures and adverse health outcomes, we aim to employ supervised methods in future epidemiologic analyses. A previous study by our research group has already reported an association between prenatal chemical mixtures and inflammation biomarkers using weighted quantile sum regression ([@R63]). Our current study identifies potential characteristics associated with chemical mixtures which can better inform future epidemiologic analyses and development of exposure reduction strategies.

Our study had a number of strengths and limitations. We were able to examine the chemical burden of an understudied population with multiple social and biological stressors. This historically understudied population of low-income, overweight, pregnant women may be uniquely vulnerable to environmental toxicants since their social positions, existing co-morbidities, and life stage may independently and synergistically amplify the adverse health effects of environmental toxicants. We also employed multiple dietary measures not commonly used in environmental health studies, including food insecurity and AHEI-P. Given our results with PFOS and food insecurity, future exploration of the relationship between dietary quality and chemical concentrations during pregnancy is warranted. We were also able to rely on biological measurements and saw consistency when utilizing multiple aggregation techniques.

Our analysis was limited to evaluating sociodemographic characteristics, so sources and timing of maternal exposure to organohalogen compounds were unknown. As this was a cross-sectional analysis, participant characteristics and chemical measurements were gathered simultaneously during pregnancy, and therefore, no causal associations can be inferred due to lack of temporality. Given each persistent organohalogen has a differing half-life in the body, our cross-sectional design and use of single-spot measurements may further introduce bias. For example, it is possible that our two PFAS groupings were based on differences in biological persistence rather than common sources of exposure. As with any biological samples, serum organohalogen biomarker measurements are subject to non-differential exposure misclassification. Given the population studied is restricted to lower-income overweight/obese pregnant women from California, and because the original study design was intended to test an intervention, the results will likely have low generalizability. With the study population comprised of women in their second trimester, it is also feasible that the results may not reflect the association among other pregnant women at different times in their pregnancy, a phenomenon referred to as left truncation. Lastly, the study population's small sample size limited our ability to perform more in-depth analyses on specific subgroups, may have reduced the precision of exposure groupings, and could have led to chance findings.

In summary, our study identified sociodemographic characteristics of both individual organohalogen chemicals and chemical groupings in an overweight/obese pregnancy cohort, adding to the growing body of literature on chemical stressors during pregnancy. Further, evidence of racial/ethnic disparities in PBDE levels, and food insecurity associated with higher PFOS levels, were identified in pregnant women, underscoring the need to target disproportionately impacted communities for environmental public health intervention. Future population health studies should utilize multiple statistical methods to understand environmental chemical exposures and their health effects across the life course.
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###### 

Baseline maternal serum PBDE (ng/g lipid) and OH-PBDE (ng/mL) concentrations^[1](#TFN1){ref-type="table-fn"}^ among MAMAS participants by select characteristics (N=98)

                                                                              GM (GSE), PBDEs (ng/g lipid)   GM (GSE), OH-PBDEs (ng/mL)                                                                                 
  -------------------------------------------------------------- ------------ ------------------------------ ---------------------------- ------------- -------------- --------------- --------------- ---------------- ---------------
  Total population                                               98 (100)     32.55 (2.76)                   8.32 (0.64)                  4.88 (0.44)   8.35 (0.76)    57.35 (4.48)    0.004 (0.001)   0.004 (0.001)    0.01 (0.002)
  MDL (% \> MDL)                                                              0.05 (100.0)                   0.03 (88.8)                  0.01 (79.6)   0.01 (90.8)    \-\--           0.003 (50.0)    0.003 (54.1)     \-\--
                                                                                                                                                                                                                        
  White/Other                                                    33 (33.67)   27.82 (2.80)                   6.94 (0.72)                  4.11 (0.51)   8.06 (1.30)    50.64 (4.84)    0.003 (0.001)   0.004 (0.001)    0.01 (0.002)
  African American                                               32 (32.65)   44.53 (7.88)                   10.90 (1.70)                 7.10 (1.34)   13.34 (1.67)   79.79 (12.79)   0.01 (0.003)    0.01 (0.003)     0.02 (0.01)
  Latina                                                         33 (33.67)   28.12 (3.90)                   7.67 (0.95)                  4.03 (0.53)   5.50 (0.79)    47.15 (5.91)    0.003 (0.001)   0.002 (0.0003)   0.005 (0.001)
  ≤ 27 years at enrollment                                       51 (52.04)   36.63 (3.57)                   9.37 (0.85)                  5.83 (0.60)   8.27 (1.12)    63.31 (5.91)    0.004 (0.001)   0.004 (0.001)    0.01 (0.002)
  \> 27 years at enrollment                                      47 (47.96)   28.64 (3.98)                   7.31 (0.90)                  4.02 (0.59)   8.45 (1.02)    51.51 (6.48)    0.003 (0.001)   0.004 (0.001)    0.01 (0.002)
  ≤ 2011 poverty level                                           44 (47.83)   35.13 (4.74)                   8.90 (1.11)                  5.38 (0.74)   8.29 (1.13)    60.59 (7.61)    0.005 (0.001)   0.003 (0.001)    0.01 (0.002)
  \> 2011 poverty level                                          48 (52.17)   30.12 (3.51)                   7.69 (0.80)                  4.61 (0.59)   9.13 (1.13)    55.00 (5.88)    0.003 (0.001)   0.005 (0.001)    0.01 (0.002)
  ≤ HS graduate                                                  34 (34.69)   39.20 (5.69)                   10.68 (1.41)                 5.52 (0.84)   8.89 (1.32)    67.46 (9.10)    0.01 (0.002)    0.004 (0.001)    0.01 (0.003)
  \> HS graduate                                                 64 (65.31)   29.50 (3.01)                   7.29 (0.66)                  4.57 (0.51)   8.08 (0.93)    52.60 (4.95)    0.003 (0.001)   0.004 (0.001)    0.01 (0.002)
  Single or other status                                         33 (33.67)   30.79 (3.56)                   8.21 (0.87)                  4.60 (0.61)   8.36 (1.30)    54.97 (5.92)    0.004 (0.001)   0.004 (0.001)    0.01 (0.002)
  In-relationship                                                65 (66.33)   33.49 (3.79)                   8.37 (0.86)                  5.03 (0.60)   8.35 (0.94)    58.59 (6.11)    0.004 (0.001)   0.004 (0.001)    0.01 (0.002)
  Marginal/high food security                                    58 (61.70)   31.34 (3.53)                   7.98 (0.80)                  4.85 (0.58)   8.72 (1.08)    56.56 (5.84)    0.004 (0.001)   0.005 (0.001)    0.01 (0.002)
  Low/very low food security                                     36 (38.30)   34.06 (4.74)                   8.93 (1.14)                  4.77 (0.72)   7.69 (1.13)    58.13 (7.59)    0.004 (0.001)   0.003 (0.001)    0.01 (0.002)
  \<50th %ile score, AHEI-P                                      47 (49.47)   34.28 (3.83)                   8.78 (0.80)                  4.98 (0.63)   8.00 (1.15)    59.25 (6.19)    0.004 (0.001)   0.003 (0.001)    0.01 (0.002)
  ≥50th %ile score, AHEI-P                                       48 (50.53)   30.58 (4.03)                   8.02 (1.01)                  4.74 (0.65)   8.58 (1.03)    55.01 (6.68)    0.003 (0.001)   0.004 (0.001)    0.01 (0.002)
  \< 14 weeks gestational age^[2](#TFN2){ref-type="table-fn"}^   25 (25.51)   27.18 (4.07)                   7.66 (0.90)                  3.69 (0.59)   6.86 (1.20)    47.72 (6.40)    0.003 (0.001)   0.002 (0.001)    0.01 (0.002)
  ≥14 weeks gestational age^[2](#TFN2){ref-type="table-fn"}^     73 (74.49)   34.63 (3.48)                   8.56 (0.81)                  5.37 (0.57)   8.94 (0.94)    61.07 (5.69)    0.004 (0.001)   0.005 (0.001)    0.01 (0.002)
  \< 30 kg/m^2^ BMI^[3](#TFN3){ref-type="table-fn"}^             54 (55.10)   28.18 (3.03)                   7.43 (0.73)                  3.97 (0.46)   8.23 (0.85)    50.38 (4.90)    0.003 (0.001)   0.003 (0.001)    0.01 (0.001)
  ≥30 kg/m^2^ BMI^[3](#TFN3){ref-type="table-fn"}^               44 (44.90)   38.86 (5.04)                   9.56 (1.13)                  6.30 (0.83)   8.51 (1.35)    67.23 (8.22)    0.006 (0.002)   0.005 (0.001)    0.02 (0.004)
  Nulliparous                                                    46 (46.94)   34.04 (4.40)                   8.75 (1.00)                  5.46 (0.75)   7.91 (1.27)    60.11 (7.40)    0.005 (0.001)   0.005 (0.001)    0.01 (0.003)
  Multiparous                                                    52 (53.06)   31.30 (3.47)                   7.96 (0.83)                  4.42 (0.52)   8.76 (0.84)    55.01 (5.44)    0.004 (0.001)   0.003 (0.001)    0.01 (0.002)
  Never smoker                                                   49 (52.69)   32.63 (4.14)                   8.52 (0.96)                  5.06 (0.65)   7.35 (0.92)    56.25 (6.60)    0.004 (0.001)   0.003 (0.001)    0.01 (0.002)
  Current or former smoker                                       44 (47.31)   32.97 (3.94)                   8.41 (0.91)                  4.72 (0.64)   9.54 (1.39)    59.56 (6.59)    0.004 (0.001)   0.004 (0.001)    0.01 (0.003)

Maternal serum concentrations were log-transformed

Measured at baseline (range: 10--24 weeks gestation)

Pre-pregnancy BMI confirmed with medical records.

Abbreviations: GM = geometric mean; GSE geometric standard error of the mean; AHEI-P = Alternative Healthy Eating Index modified for Pregnancy.

###### 

Baseline maternal serum PCB (ng/g lipid) and PFAS (ng/mL) concentrations^[1](#TFN5){ref-type="table-fn"}^ among MAMAS cohort participants by select characteristics (N=98)

                                                                              GM (GSE), PCBs (ng/g lipid)   GM (GSE), PFASs (ng/mL)                                                                                                        
  -------------------------------------------------------------- ------------ ----------------------------- ------------------------- ------------- -------------- -------------- ------------- -------------- ------------- ------------- -------------
  Total population                                               98 (100)     2.26 (0.21)                   3.95 (0.25)               2.08 (0.21)   8.88 (0.61)    0.58 (0.03)    0.18 (0.01)   2.95 (0.16)    1.21 (0.09)   0.54 (0.04)   5.94 (0.27)
  MDL (% \> MDL)                                                              0.01 (56.1)                   0.01 (87.8)               0.01 (57.1)   \-\--          0.07 (100.0)   0.12 (69.4)   0.27 (100.0)   0.05 (98.0)   0.04 (99.0)   \-\--
                                                                                                                                                                                                                                           
  White/Other                                                    33 (33.67)   2.89 (0.46)                   4.24 (0.55)               2.55 (0.41)   10.41 (1.40)   0.51 (0.05)    0.17 (0.02)   2.74 (0.26)    1.19 (0.14)   0.52 (0.07)   5.48 (0.44)
  African American                                               32 (32.65)   1.95 (0.32)                   4.01 (0.35)               1.89 (0.22)   8.44 (0.83)    0.67 (0.06)    0.18 (0.02)   2.77 (0.26)    1.32 (0.13)   0.48 (0.06)   5.78 (0.45)
  Latina                                                         33 (33.67)   2.05 (0.30)                   3.64 (0.40)               1.86 (0.26)   7.95 (0.90)    0.58 (0.05)    0.19 (0.03)   3.37 (0.33)    1.12 (0.19)   0.63 (0.09)   6.62 (0.50)
  ≤ 27 years at enrollment                                       51 (52.04)   1.59 (0.16)                   3.05 (0.22)               1.33 (0.11)   6.28 (0.45)    0.57 (0.04)    0.19 (0.02)   2.99 (0.25)    1.14 (0.14)   0.57 (0.06)   6.04 (0.42)
  \> 27 years at enrollment                                      47 (47.96)   3.31 (0.45)                   5.23 (0.48)               3.38 (0.38)   12.92 (1.19)   0.60 (0.04)    0.17 (0.02)   2.91 (0.21)    1.28 (0.11)   0.51 (0.06)   5.83 (0.34)
  ≤ 2011 poverty level                                           44 (47.83)   1.82 (0.22)                   3.64 (0.31)               1.72 (0.19)   7.55 (0.67)    0.60 (0.05)    0.18 (0.02)   2.93 (0.22)    1.23 (0.14)   0.56 (0.06)   6.03 (0.35)
  \> 2011 poverty level                                          48 (52.17)   3.03 (0.40)                   4.52 (0.44)               2.68 (0.32)   11.08 (1.10)   0.55 (0.04)    0.18 (0.02)   2.93 (0.26)    1.17 (0.13)   0.52 (0.06)   5.80 (0.43)
  ≤ HS graduate                                                  34 (34.69)   1.69 (0.23)                   3.28 (0.29)               1.57 (0.20)   7.01 (0.66)    0.61 (0.06)    0.19 (0.03)   3.00 (0.25)    1.24 (0.16)   0.51 (0.07)   6.09 (0.39)
  \> HS graduate                                                 64 (65.31)   2.64 (0.30)                   4.37 (0.36)               2.42 (0.25)   10.06 (0.88)   0.57 (0.04)    0.18 (0.02)   2.92 (0.21)    1.19 (0.11)   0.56 (0.06)   5.86 (0.36)
  Single or other status                                         33 (33.67)   2.30 (0.37)                   4.20 (0.50)               2.50 (0.36)   9.54 (1.15)    0.67 (0.07)    0.19 (0.03)   3.03 (0.24)    1.38 (0.13)   0.49 (0.06)   6.14 (0.42)
  In-relationship                                                65 (66.33)   2.24 (0.25)                   3.83 (0.29)               1.89 (0.19)   8.56 (0.70)    0.54 (0.03)    0.18 (0.02)   2.91 (0.21)    1.13 (0.12)   0.57 (0.06)   5.84 (0.35)
  Marginal/high food security                                    58 (61.70)   2.34 (0.30)                   4.10 (0.34)               2.21 (0.25)   9.39 (0.86)    0.57 (0.04)    0.18 (0.02)   2.66 (0.18)    1.14 (0.11)   0.51 (0.05)   5.51 (0.31)
  Low/very low food security                                     36 (38.30)   2.09 (0.29)                   3.77 (0.38)               1.89 (0.23)   8.14 (0.84)    0.59 (0.05)    0.17 (0.02)   3.47 (0.34)    1.30 (0.16)   0.59 (0.08)   6.65 (0.54)
  \<50th %ile score, AHEI-P                                      47 (49.47)   2.15 (0.26)                   3.88 (0.31)               1.83 (0.20)   8.38 (0.71)    0.59 (0.05)    0.16 (0.02)   2.98 (0.24)    1.15 (0.13)   0.49 (0.06)   5.86 (0.40)
  ≥50th %ile score, AHEI-P                                       48 (50.53)   2.37 (0.33)                   4.06 (0.41)               2.35 (0.31)   9.45 (1.03)    0.57 (0.04)    0.19 (0.02)   2.96 (0.23)    1.24 (0.13)   0.60 (0.07)   6.05 (0.37)
  \< 14 weeks gestational age^[2](#TFN6){ref-type="table-fn"}^   25 (25.51)   1.89 (0.38)                   3.72 (0.52)               1.97 (0.33)   8.23 (1.18)    0.63 (0.07)    0.20 (0.03)   3.05 (0.26)    1.37 (0.24)   0.56 (0.07)   6.22 (0.54)
  ≥14 weeks gestational age^[2](#TFN6){ref-type="table-fn"}^     73 (74.49)   2.41 (0.24)                   4.04 (0.29)               2.12 (0.20)   9.11 (0.70)    0.57 (0.03)    0.18 (0.02)   2.92 (0.20)    1.15 (0.09)   0.53 (0.05)   5.85 (0.31)
  \< 30 kg/m^2^ BMI^[3](#TFN7){ref-type="table-fn"}^             54 (55.10)   2.14 (0.27)                   4.44 (0.39)               2.44 (0.29)   9.47 (0.90)    0.58 (0.05)    0.18 (0.02)   3.01 (0.23)    1.19 (0.13)   0.52 (0.05)   5.99 (0.39)
  ≥30 kg/m^2^ BMI^[3](#TFN7){ref-type="table-fn"}^               44 (44.90)   2.42 (0.33)                   3.43 (0.30)               1.70 (0.19)   8.20 (0.79)    0.58 (0.04)    0.18 (0.02)   2.87 (0.24)    1.22 (0.12)   0.57 (0.07)   5.88 (0.36)
  Nulliparous                                                    46 (46.94)   2.34 (0.34)                   3.79 (0.39)               1.95 (0.26)   8.91 (0.97)    0.60 (0.04)    0.18 (0.02)   3.12 (0.27)    1.36 (0.13)   0.56 (0.06)   6.41 (0.36)
  Multiparous                                                    52 (53.06)   2.19 (0.25)                   4.10 (0.32)               2.20 (0.22)   8.85 (0.75)    0.56 (0.04)    0.18 (0.02)   2.81 (0.20)    1.08 (0.12)   0.52 (0.06)   5.55 (0.38)
  Never smoker                                                   49 (52.69)   2.29 (0.28)                   3.88 (0.36)               1.96 (0.23)   8.61 (0.82)    0.57 (0.04)    0.21 (0.02)   3.01 (0.25)    1.20 (0.14)   0.55 (0.06)   6.11 (0.42)
  Current or former smoker                                       44 (47.31)   2.17 (0.32)                   4.04 (0.38)               2.18 (0.27)   9.12 (0.94)    0.58 (0.04)    0.16 (0.02)   2.81 (0.22)    1.20 (0.12)   0.51 (0.06)   5.61 (0.35)

Maternal serum concentrations were log-transformed

Measured at baseline (range: 10--24 weeks gestation)

Pre-pregnancy BMI confirmed with medical records.

Abbreviations: GM = geometric mean; GSE = geometric standard error of the mean; AHEIP = Alternative Healthy Eating Index modified for Pregnancy; BMI = body mass index.

###### 

Associations between log-transformed maternal serum PBDE (ng/g lipid) and OH-PBDE (ng/mL) concentrations and participant characteristics

                  African American^[1](#TFN10){ref-type="table-fn"}^   Latina^[1](#TFN10){ref-type="table-fn"}^   \>HS graduate^[2](#TFN11){ref-type="table-fn"}^   Pre-pregnancy BMI   Parity                  Adj R-squared                                                                             
  --------------- ---------------------------------------------------- ------------------------------------------ ------------------------------------------------- ------------------- ----------------------- --------------- ----------------------- ----------- -------------------------- ---------- ------
  ln-BDE-47       0.37 (−0.04, 0.78)                                   0.07                                       −0.04 (−0.44, 0.36)                               0.85                0.26 (−0.09, 0.61)      0.15            0.04 (−0.001, 0.08)     0.05        −0.13 (−0.29, 0.04)        0.14       0.15
  ln-BDE-99       0.36 (−0.01, 0.73)                                   0.06                                       0.02 (−0.34, 0.38)                                0.92                **0.36 (0.04, 0.69)**   **0.03**        0.02 (−0.01, 0.06)      0.16        −0.12 (−0.27, 0.03)        0.12       0.15
  ln-BDE-100      **0.45 (0.03, 0.87)**                                **0.04**                                   −0.03 (−0.44, 0.38)                               0.89                0.15 (−0.21, 0.52)      0.40            **0.06 (0.02, 0.10)**   **0.004**   **−0.19 (−0.36, −0.01)**   **0.04**   0.21
  ln-BDE-153      **0.47 (0.03, 0.91)**                                **0.03**                                   −0.41 (−0.83, 0.02)                               0.06                0.13 (−0.25, 0.50)      0.50            0.01 (−0.03, 0.05)      0.56        −0.06 (−0.24, 0.12)        0.50       0.17
  ln-ΣPBDEs       0.37 (−0.001, 0.75)                                  0.05                                       −0.12 (−0.48, 0.25)                               0.53                0.24 (−0.08, 0.57)      0.13            0.03 (−0.001, 0.07)     0.06        −0.13 (−0.28, 0.02)        0.09       0.17
                                                                                                                                                                                                                                                                                                          
  ln-5-OHBDE-47   0.97 (−0.02, 1.96)                                   0.05                                       −0.23 (−1.20, 0.74)                               0.64                0.54 (−0.31, 1.40)      0.21            0.07 (−0.03, 0.16)      0.16        −0.41 (−0.81, −0.001)      0.05       0.14
  ln-6-OHBDE-47   0.70 (−0.10, 1.49)                                   0.08                                       **−0.93 (−1.70, −0.16)**                          **0.02**            0.13 (−0.56, 0.81)      0.71            0.05 (−0.03, 0.12)      0.19        −0.28 (−0.60, 0.05)        0.10       0.21
  Ln-ΣOH-PBDEs    0.58 (−0.08, 1.24)                                   0.08                                       **−0.85 (−1.49, −0.21)**                          **0.01**            0.31 (−0.26, 0.88)      0.28            0.04 (−0.02, 0.11)      0.17        **−0.31 (−0.58, −0.04)**   **0.02**   0.24

Categorical reference groups:

White or other race/ethnicity

≤high school graduate.

Bolded value indicates p\<0.05

###### 

Associations between log-transformed maternal serum PCB (ng/g lipid) and PFAS (ng/mL) concentrations and participant characteristics

               Maternal age (years)    ≤Poverty level^[1](#TFN14){ref-type="table-fn"}^   Low/very low food security^[2](#TFN15){ref-type="table-fn"}^   Adj R-squared                                      
  ------------ ----------------------- -------------------------------------------------- -------------------------------------------------------------- --------------- ----------------------- ---------- -------
  ln-PCB-138   **0.08 (0.05, 0.11)**   **\<0.0001**                                       **−0.35 (−0.67, −0.02)**                                       **0.04**                                           0.31
  ln-PCB-153   **0.06 (0.04, 0.08)**   **\<0.0001**                                       −0.10 (−0.32, 0.13)                                            0.40                                               0.29
  ln-PCB-180   **0.10 (0.07, 0.12)**   **\<0.0001**                                       −0.25 (−0.50, 0.01)                                            0.06                                               0.47
  ln-ΣPCBs     **0.08 (0.06, 0.09)**   **\<0.0001**                                       **−0.23 (−0.44, −0.02)**                                       **0.03**                                           0.47
                                                                                                                                                                                                            
  ln-PFNA                                                                                                                                                                0.04 (−0.18, 0.25)      0.74       0.001
  ln-PFDeA                                                                                                                                                               −0.07 (−0.41, 0.28)     0.71       0.002
  ln-PFOS                                                                                                                                                                **0.27 (0.04, 0.50)**   **0.02**   0.05
  ln-PFOA                                                                                                                                                                0.13 (−0.19, 0.45)      0.43       0.007
  ln-PFHxS                                                                                                                                                               0.14 (−0.20, 0.47)      0.42       0.007
  ln-ΣPFAS                                                                                                                                                               0.19 (−0.003, 0.38)     0.05       0.04

Categorical reference groups:

\>2011 federal poverty level

marginal/high food security

Bolded value indicates p\<0.05

###### 

Maternal serum chemical loading on the first four principal components, based on an eigenvalue of \>50 for varimax rotated components

  Analyte                   Component 1   Component 2   Component 3   Component 4
  ------------------------- ------------- ------------- ------------- -------------
  BDE-47                                                              
                                                                      
  BDE-99                                                              
                                                                      
  BDE-100                                                             
                                                                      
  BDE-153                                                             
                                                                      
  5-OHBDE-47                                                          
                                                                      
  6-OHBDE-47                                                          
                                                                      
  PCB-138                                                             
                                                                      
  PCB-153                                                             
                                                                      
  PCB-180                                                             
                                                                      
  PFNA                                                                
                                                                      
  PFDeA                                                               
                                                                      
  PFOS                                                                
                                                                      
  PFOA                                                                
                                                                      
  PFHxS                                                               
                                                                      
  **Variance Explained:**   **28%**       **18%**       **16%**       **8%**

###### 

Associations between principal components and participant sociodemographic characteristics.

                                PC1 (BDE-47,-99,-100, -153, 5-OHBDE-47, 6-OHBDE-47)   PC2 (PCB-138, -153, -180)   PC3 (PFNA, PFDeA, PFOA)    PC4 (PFOS, PFHxS)                                                      
  ----------------------------- ----------------------------------------------------- --------------------------- -------------------------- ------------------- --------------------- ------ --------------------- ------
  White or Other (Ref)          1                                                                                 1                                              1                            1                     
  African American              **0.62 (0.16, 1.09)**                                 **0.009**                   −0.07 (−0.43, 0.30)        0.72                0.28 (−0.24, 0.81)    0.28   0.10 (−0.41, 0.61)    0.70
  Latina                        −0.10 (−0.56, 0.36)                                   0.67                        0.01 (−0.35, 0.37)         0.97                −0.06 (−0.57, 0.45)   0.81   0.48 (−0.18, 0.99)    0.06
  Maternal age (years)          −0.01 (−0.05, 0.02)                                   0.56                        **0.13 (0.10, 016)**       **\<0.0001**        0.005 (−0.04, 0.04)   0.81   0.02 (−0.17, 0.06)    0.27
  Parity                        −0.17 (−0.38, 0.03)                                   0.09                        **−0.24 (−0.40, −0.08)**   **0.004**           0.02 (−0.21, 0.24)    0.88   −0.20 (−0.42, 0.03)   0.08
  Pre-pregnancy BMI (kg/m^2^)   **0.05 (0.01, 0.10)**                                 **0.02**                    −0.01 (−0.05, 0.02)        0.40                −0.01 (−0.05, 0.04)   0.82   0.01 (−0.04, 0.06)    0.65

Bolded value indicates p\<0.05.

Abbreviations: PC = principal component.
